Abstracts Archive - Page 2497 of 2605 - ACR Meeting Abstracts

Abstract Number: 1594 • 2012 ACR/ARHP Annual Meeting
Clinical and Radiological Outcomes After One Year of Remission Steered Combination Treatment in Patients with Early Rheumatoid and Undifferentiated Arthritis
L. Heimans¹, K.V.C. Wevers-de Boer¹, K. Visser¹, H.K. Ronday², M. van Oosterhout³, J. H. L. M. Van Groenendael⁴, A.J. Peeters⁵, G. Steup-Beekman⁶, G. Collee⁷, P.B.J Sonnaville⁸, B.A. Grillet⁹, Tom Huizinga¹ and C.F. Allaart¹, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, Haga Hospital, The Hague, Netherlands, ³Rheumatology, Groene Hart Hospital, Gouda, Netherlands, ⁴Franciscus Hospital, Roosendaal, Netherlands, ⁵Rheumatology, Reinier de Graaf Gasthuis, Delft, Netherlands, ⁶Rheumatology, Bronovo Hospital, Netherlands, ⁷MCH, The Hague, Netherlands, ⁸Admiraal de Ruyter Ziekenhuis, Goes, Netherlands, ⁹Department of Rheumatology, Zorgsaam Hospital, Terneuzen, Netherlands
Background/Purpose: To evaluate the 1 year clinical and radiological outcomes of remission steered therapy in early arthritis patients treated aiming at remission (DAS
Abstract Number: 1595 • 2012 ACR/ARHP Annual Meeting
Genome-Wide Association Study to High -Throughput Cell-Based Phenotypic Screen Identifies Novel Chemical Inhibitors of CD40 Signaling
Gang Li¹, Dorothee Diogo², Di Wu¹, Jim Spoonamore³, Rheumatoid Arthritis Consortium International (RACI)⁴, Eli Stahl⁵, Nicola Tolliday³ and Robert M. Plenge⁶, ¹Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, ³Broad Institute, Cambridge, MA, ⁴Boston, ⁵Brigham and Women's Hospital, ⁶Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Deriving therapeutic targets from human genetics linked with biological alterations of risk alleles may provide a more successful approach to drug development than traditional…
Abstract Number: 1596 • 2012 ACR/ARHP Annual Meeting
Strontium Ranelate in Knee Osteoarthritis Trial (SEKOIA): A Structural and Symptomatic Efficacy
Jean-Yves Reginster¹, R. Chapurlat², Claus Christiansen³, H. Genant⁴, N. Bellamy⁵, W. Bensen⁶, F. Navarro⁷, J. Badurski⁸, E. Nasonov⁹, X. Chevalier¹⁰, PN. Sambrook¹¹, T. Spector¹² and Cyrus Cooper¹³, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²Service de Rhumatologie et Pathologie Osseuse, INSERM UMR 1033 and Université de Lyon, Hôpital Edouard Herriot, Lyon, France, ³CCBR, Ballerup, Denmark, ⁴Radiology, Medicine and Orthopaedic Surgery University of California and Synarc, San Francisco, CA, ⁵CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, ⁶St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, ⁷Servicio de Reumatologia, H. Universitario Virgen de la Macarena, Sevilla, Spain, ⁸Center of Osteoporosis and Osteo-articular Diseases, Bialystock, Poland, ⁹ARBITER, Inst of Rheumatology, Moscow, Russia, ¹⁰Service de Rhumatologie, Hôpital Henri-Mondor, Creteil, France, ¹¹Department of Rheumatology, Royal North Shore Hospital, St Leonards, Australia, ¹²Dept of Twin Research and Genetic Epidemiology, King's College London, St. Thomas Campus, London, United Kingdom, ¹³NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom
Background/Purpose: Treatments for osteoarthritis focus on improving symptoms through non-pharmacological and pharmacological approaches. Strontium ranelate (SrRan), a treatment for osteoporosis, was shown to stimulate cartilage…
Abstract Number: 1557 • 2012 ACR/ARHP Annual Meeting
What Percentage of Postmenopausal Women Younger Than Age 65 Years Have Low Bone Mineral Density At a Family Health Center?
Marvin Vaishnani¹ and Feyrouz T. Al-Ashkar², ¹Rheumatic and Immunologic diseases, Cleveland Clinic,Lorain Institute, Lorain, OH, ²Rheumatic and Immunologic Diseases, Cleveland Clinic,Lorain Institute, Lorain, OH
Background/Purpose: Many younger women, < 65 years of age may have low bone mineral density (BMD) that remains undetected in clinical practice due to following…
Abstract Number: 1558 • 2012 ACR/ARHP Annual Meeting
“It Gets Me Down Every Single Day”: Are Men with Rheumatoid Arthritis Getting the Support They Need?
Caroline A. Flurey¹, Marianne Morris², Jon Pollock¹, Rodney A. Hughes³, Pamela Richards⁴ and Sarah Hewlett⁵, ¹Faculty of Health and Life Sciences, University of the West of England, Bristol, United Kingdom, ²University of the West of England, Bristol, United Kingdom, ³Rheumatology, St. Peters Hospital, Chertsey Surrey, United Kingdom, ⁴Academic Rheumatology Unit, University of Bristol, Bristol, United Kingdom, ⁵Academic Rheumatology, University of the West of England, Bristol, United Kingdom
Background/Purpose: Daily life with RA has been explained as unpredictable and full of uncertainty. However, most research about daily life with RA was conducted before…
Abstract Number: 1559 • 2012 ACR/ARHP Annual Meeting
Treatment Outcomes From a Nurse-Led Rheumatology Clinic in Monitoring of anti-TNF Therapy – a Randomised Controlled Trial
Ingrid Larsson¹, Bengt Fridlund¹, Barbro Arvidsson², Annika Teleman³ and Stefan Bergman⁴, ¹Jönköping University, Jönköping, School of Health Sciences, Jönköping University, Jönköping, Sweden, ²Halmstad University, School of Social and Health Sciences, Halmstad University, Halmstad, Sweden, ³Spenshults Hosp of Rheum Dis, Oskarstrom, Sweden, ⁴Spenshult Hospital, R&D Center, Spenshult Hospital, Oskarström, Sweden
Background/Purpose: Patients with chronic inflammatory arthritis (CIA) treated with anti-TNF therapy are usually followed up by rheumatologists. Nurse-led rheumatology clinics have been proposed for patients…
Abstract Number: 1560 • 2012 ACR/ARHP Annual Meeting
What Will Determine Adherence to Pharmaceutical Treatment for Rheumatoid Arthritis? A Systematic Review
Annelieke Pasma¹, Adriaan van 't Spijker², Jan van Busschbach³, Johanna M.W. Hazes⁴ and Jolanda J. Luime⁵, ¹Rheumatology, Erasmus MC University Medical Center, Rotterdam, Netherlands, ²Psychiatry, section Medical Psychology and Psychotherapy, Erasmus MC University Medical Center, Rotterdam, Netherlands, ³Medical Psychology and Psychotherapy, Erasmus MC - University Medical Center, Rotterdam, Netherlands, ⁴Rheumatology, Erasmus MC, Rotterdam, Netherlands, ⁵Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands
Background/Purpose: In the early stages of Rheumatoid Arthritis (RA), adherence to the prescribed treatment is important to prevent irreversible joint damage. However, medication adherence rates…
Abstract Number: 1561 • 2012 ACR/ARHP Annual Meeting
Factors Influencing Implementation of Intensive Treatment Strategies for Early Rheumatoid Arthritis
Sabrina Meyfroidt¹, Diederik De Cock¹, Kristien Van der Elst², Laura van Hulst³, Marlies Hulscher³, Johan Joly⁴, Rene Westhovens⁵ and Patrick Verschueren⁵, ¹Skeletal Biology and Engineering Research Center, Department of Development and Regeneration, KU Leuven, Leuven, Belgium, ²Department of Development and Regeneration, Neuro-musculo-skeletal Research Unit, University Hospitals KULeuven, Leuven, Belgium, ³Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ⁴University Hospitals Leuven on behalf of the CareRA Study Group, Leuven, Belgium, ⁵Rheumatology, University Hospitals KULeuven, Leuven, Belgium
Background/Purpose: Despite the availability and demonstrated effectiveness of intensive treatment strategies for early rheumatoid arthritis (RA), a discrepancy seems to exist between theoretical acceptance and…
Abstract Number: 1562 • 2012 ACR/ARHP Annual Meeting
Benign Joint Hypermobility Syndrome More Common Than Expected,Both in Controls and in SLE Patients
Pia Malcus-Johnsson¹, Lotta Köhlin¹, Gunnar K. Sturfelt² and Ola Nived³, ¹Department of Rheumatology, University Hospital, Lund, Sweden, ²Department of Rheumatology, University Hospital Lund, Lund, Sweden, ³Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden
Background/Purpose: Benign joint hypermobility syndrome(BJHS) in connection to rheumatic disease is sparsely investigated. It has been postulated that BJHS is more frequent in SLE than…
Abstract Number: 1563 • 2012 ACR/ARHP Annual Meeting
Is Automated DATA Capture As Reliable As Manual DATA Entry in Survey Based Research?
Rachel A. Mikolaitis¹, Jessica Cornejo², Chris Alonzo¹, Joel A. Block¹ and Meenakshi Jolly², ¹Section of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: The collection of patient reported outcomes requires accruing survey data from patients during routine medical visits. Many of these are paper-based and require manual…
Abstract Number: 1564 • 2012 ACR/ARHP Annual Meeting
Misperceptions of FMS Patients about Their Disease
Robert S. Katz¹, Hannah Bond², Jessica L. Polyak², Lauren Kwan² and Susan Shott¹, ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: What do fibromyalgia patients think causes their illness. We asked fibromyalgia syndrome patients to respond to a questionnaire which asked about potential etiologic factors.…
Abstract Number: 1565 • 2012 ACR/ARHP Annual Meeting
How FMS Patients Become Workaholics
Robert S. Katz¹, Hannah Bond², Jessica L. Polyak², Lauren Kwan² and Susan Shott¹, ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Many patients with the fibromyalgia syndrome (FMS) bring in disability forms for the practitioner to fill out or have Social Security Disability applications requesting medical…
Abstract Number: 1566 • 2012 ACR/ARHP Annual Meeting
Fibromyalgia’s Impact On Relationships
Robert S. Katz¹, Alexandra Small², Sharon M. Ferbert³ and Susan Shott¹, ¹Rush University Medical Center, Chicago, IL, ²University of Illinois Medical School, Chicago, IL, ³Advocates for Funding Fibromyalgia Treatment, Education and Research(AFFTER), Libertyville, IL
Background/Purpose: The Fibromyalgia Syndrome (FMS) can place a strain on patients’ personal relationships. Having a close support network is helpful in coping with illnesses, but chronic…
Abstract Number: 1567 • 2012 ACR/ARHP Annual Meeting
Sleep Study with Armband Device in Fibromyalgia Patients: Fibromyalgia Patients Don’t Rest Their Weary Muscles
Robert S. Katz¹, Alexandra Small², Ben J. Small³ and Jessica L. Polyak⁴, ¹Rush University Medical Center, Chicago, IL, ²University of Illinois Medical School, Chicago, IL, ³MacNeal Hospital, Berwyn, IL, ⁴Rheumatology Associates, Chicago, IL
Background/Purpose: Patients with the fibromyalgia syndrome (FMS) have frequent awakenings and poor sleep efficiency. The purpose of this study is to evaluate sleep patterns in…
Abstract Number: 1568 • 2012 ACR/ARHP Annual Meeting
A Survey Study of Methotrexate Use by Rheumatologists and Their Patients with Rheumatoid Arthritis
Peter Nash¹ and Dave Nicholls², ¹University of Queensland, Brisbane, Australia, ²Coast Joint Care, Maroochydore, Australia
Background/Purpose: Methotrexate (MTX) is the anchor medication for the management of rheumatoid arthritis (RA); however there is limited patient-focused data available on the use of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].